UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$2,349,0090.0%25,8360.0%0.00%0.0%
Q1 2023$2,349,009
+159.7%
25,836
+8.5%
0.00%
Q4 2022$904,466
-99.8%
23,808
+6.9%
0.00%
Q3 2022$559,595,000
-43.2%
22,268
-31.3%
0.00%
-100.0%
Q2 2022$985,456,000
+4.9%
32,427
+13.0%
0.00%
Q1 2022$939,721,000
+36.8%
28,685
+10.1%
0.00%
Q4 2021$686,727,000
-78.1%
26,042
-16.3%
0.00%
-100.0%
Q3 2021$3,129,475,000
-30.8%
31,105
-2.7%
0.00%
-50.0%
Q2 2021$4,522,451,000
+19.3%
31,954
-16.0%
0.00%0.0%
Q1 2021$3,791,391,000
-20.1%
38,028
-1.0%
0.00%0.0%
Q4 2020$4,747,009,000
+48.5%
38,400
+17.1%
0.00%0.0%
Q3 2020$3,195,669,000
-35.9%
32,803
+2.6%
0.00%
-33.3%
Q2 2020$4,987,021,000
+47.1%
31,964
+36.1%
0.00%
+50.0%
Q1 2020$3,390,113,000
-24.6%
23,487
+6.8%
0.00%
-33.3%
Q4 2019$4,494,393,000
+185.2%
21,985
+12.0%
0.00%
+200.0%
Q3 2019$1,575,692,000
+10.9%
19,625
+30.3%
0.00%0.0%
Q2 2019$1,421,383,000
+60.3%
15,065
+45.2%
0.00%0.0%
Q1 2019$886,580,000
+80.8%
10,373
+18.7%
0.00%
Q4 2018$490,370,000
-31.4%
8,7410.0%0.00%
-100.0%
Q3 2018$714,664,000
-80.1%
8,741
-95.0%
0.00%
-66.7%
Q1 2018$3,591,220,000
-31.1%
175,096
-4.8%
0.00%
-25.0%
Q4 2017$5,210,796,000
-10.3%
183,997
-1.5%
0.00%
-20.0%
Q3 2017$5,809,169,000186,7900.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$295,368,02659.26%
Ally Bridge Group (NY) LLC 105,558$10,762,69413.04%
First Light Asset Management, LLC 1,432,208$146,027,92811.44%
Boxer Capital, LLC 1,430,004$145,8036.76%
MPM BioImpact LLC 234,478$23,907,3774.81%
Tri Locum Partners LP 96,274$9,816,0973.65%
Altium Capital Management LP 41,485$4,229,8113.20%
Ghost Tree Capital, LLC 85,000$8,666,6002.86%
KRS Capital Management, LLC 27,941$2,848,8642.85%
Sofinnova Investments, Inc. 322,471$32,879,1432.15%
View complete list of REATA PHARMACEUTICALS INC shareholders